Technology News and Research

RSS

Alexion announces acquisition of Taligen Therapeutics

Alexion Pharmaceuticals, announced that it has acquired Taligen Therapeutics, a privately held development-stage biotechnology company based in Cambridge, Mass.

31 Jan 2011

Inovio announces regulatory approval for Phase 2 trial to treat leukemia using new vaccine delivery device

Inovio Pharmaceuticals, a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the regulatory approval of a Phase 2 clinical trial to treat leukemia utilizing Inovio's new ELGEN 1000 automated vaccine delivery device.

31 Jan 2011

Sorin Group announces commercial availability of Perceval S aortic heart valve in Europe

Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announces the commercial availability in Europe of the self- anchoring Perceval S aortic heart valve. The innovative next-generation valve represents the latest innovation in heart valve technology.

31 Jan 2011

Blind individual drives street vehicle independently

The National Federation of the Blind, the oldest and largest organization of blind people in the nation, announced today that for the first time a blind individual has driven a street vehicle in public without the assistance of a sighted person.

30 Jan 2011

Scientists convert adult skin cells into cardiomyocytes using direct reprogramming strategy

Scripps Research Institute scientists have converted adult skin cells directly into beating heart cells efficiently without having to first go through the laborious process of generating embryonic-like stem cells. The powerful general technology platform could lead to new treatments for a range of diseases and injuries involving cell loss or damage, such as heart disease, Parkinson's, and Alzheimer's disease.

30 Jan 2011

Chrissie Fletcher joins Pharma IQ to discuss about Health Technology Assessment

Chrissie Fletcher joined Pharma IQ to talk about Health Technology Assessment. In this comprehensive podcast, she discussed how she sees health economists and statisticians interacting going forwards, why there is so much emphasis on reporting for reimbursement and whether she expects pharma companies will try and do this more in-house, in the future.

29 Jan 2011

NexMed presents data on NexACT technology use to improve less permeable, soluable oral drugs

Apricus Biosciences, today announced that its research and development team at its NexMed, USA, Inc. subsidiary is presenting data demonstrating the use of the Company's proprietary NexACT technology to improve less permeable or less soluable drugs, at the Controlled Release Society Product Development Forum for Poorly Soluble Drugs, being held January 27 to 29, 2011, in Miami, Florida.

29 Jan 2011

Published paper suggests some orthodontists may expose young patients to unnecessary radiation

Some orthodontists may be exposing young patients to unnecessary radiation when they order 3-D X-ray imaging for simple orthodontic cases before considering traditional 2-D imaging, suggests a paper published by University of Michigan faculty.

29 Jan 2011

Viral Genetics enters binding Release and Settlement Agreement with T&T

Viral Genetics, and its President, Haig Keledjian, have entered into a binding Release and Settlement Agreement with Timothy and Thomas LLC and its principals that was approved by the court.

29 Jan 2011

ISU researchers study parasites that cause NTDs in humans

Richard Martin, DVM, PhD, a biomedical sciences professor at Iowa State University's College of Veterinary Medicine, has devoted his 35-year career to studying nematode parasites. These parasites infect approximately one-quarter of the world population, producing debilitating symptoms that devastate the lives and economies of many of the world's underdeveloped and impoverished areas.

29 Jan 2011

dbMotion completes interoperability testing at Annual IHE North American Connectathon

dbMotion, a provider of health interoperability solutions, today announced it successfully completed interoperability testing at the 12th Annual IHE North American Connectathon in Chicago.

29 Jan 2011

North Shore-LIJ seeks patients with early-stage prostate cancer to participate in Phase I study

The North Shore-LIJ Health System Department of Radiation Medicine announced today it is seeking patients with early-stage prostate cancer to participate in a Phase I Research study.

29 Jan 2011

FWC selects athenahealth's EHR service to provide high-quality care

athenahealth, Inc., a leading provider of web-based practice management, electronic health record, and patient communication services to medical groups, today announced that Florida Woman Care, one of the largest OB/GYN medical groups in Florida, has selected athenahealth's EHR service, athenaClinicals, to provide to its network of 170 physicians a fully scalable, and cost-effective way to share health information, ultimately bringing efficiencies to FWC's workflow and improving its ability to deliver coordinated, high-quality care.

29 Jan 2011

Covalon Technologies' annual revenue up 54%

Covalon Technologies Ltd., an advanced medical technologies company, today announced the following financial results for its year ended September 30, 2010

29 Jan 2011

Awarepoint ends 2010 with 91 hospital sites contract containing RTLS network coverage

Awarepoint Corporation, a privately held San Diego-based corporation, today announced it ended 2010 with 91 hospital sites contracted consisting of 45,062,013 million square feet of real-time location system network coverage in U.S. hospitals and 135,265 healthcare assets under management.

29 Jan 2011

Research roundup: Barriers to trauma care, immunizations; Small business tax credit; Medicare coverage of preventive care

Possible Geographical Barriers To Trauma Center Access For Vulnerable Patients In The United States - This study analyzes disparities in geographic access to trauma centers in 2005, drawing from data from the 2005 American Hospital Association annual survey.

29 Jan 2011

BioTime announces acquisition of CTI assets

BioTime, today announced that it has acquired substantially all the assets of Cell Targeting, a Cleveland, Ohio-based biotechnology company conducting research in regenerative medicine.

29 Jan 2011

FDA approves Arteriocyte's Magellan MAR01 technology for Phase I trial to treat CLI

Arteriocyte, a leading clinical stage biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts that develops proprietary stem cell and tissue engineering based therapies, announced today approval from the Food and Drug Administration to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Critical Limb Ischemia.

29 Jan 2011

UMMS, Lundbeck announce research collaboration to develop targeted therapy for HD

The University of Massachusetts Medical School and Lundbeck Inc. today announced a research collaboration aimed at further development of a targeted therapy to slow or halt the progression of Huntington's disease.

29 Jan 2011

The Methodist Hospital in Houston opens surgical training center

Today The Methodist Hospital in Houston opened the Methodist Institute for Technology, Innovation and Education, a 35,000 square-foot interactive, simulation-based surgical training center created to help practicing physicians acquire new high-tech skills including image-guided therapies, surgical robotics and new techniques.

29 Jan 2011

Technology News and Research

Alexion announces acquisition of Taligen Therapeutics

Inovio announces regulatory approval for Phase 2 trial to treat leukemia using new vaccine delivery device

Sorin Group announces commercial availability of Perceval S aortic heart valve in Europe

Blind individual drives street vehicle independently

Scientists convert adult skin cells into cardiomyocytes using direct reprogramming strategy

Chrissie Fletcher joins Pharma IQ to discuss about Health Technology Assessment

NexMed presents data on NexACT technology use to improve less permeable, soluable oral drugs

Published paper suggests some orthodontists may expose young patients to unnecessary radiation

Viral Genetics enters binding Release and Settlement Agreement with T&T

ISU researchers study parasites that cause NTDs in humans

dbMotion completes interoperability testing at Annual IHE North American Connectathon

North Shore-LIJ seeks patients with early-stage prostate cancer to participate in Phase I study

FWC selects athenahealth's EHR service to provide high-quality care

Covalon Technologies' annual revenue up 54%

Awarepoint ends 2010 with 91 hospital sites contract containing RTLS network coverage

Research roundup: Barriers to trauma care, immunizations; Small business tax credit; Medicare coverage of preventive care

BioTime announces acquisition of CTI assets

FDA approves Arteriocyte's Magellan MAR01 technology for Phase I trial to treat CLI

UMMS, Lundbeck announce research collaboration to develop targeted therapy for HD

The Methodist Hospital in Houston opens surgical training center

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News